120 related articles for article (PubMed ID: 8980402)
1. The expression and localisation of beta-nerve growth factor (beta-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation.
Paul AB; Grant ES; Habib FK
Br J Cancer; 1996 Dec; 74(12):1990-6. PubMed ID: 8980402
[TBL] [Abstract][Full Text] [Related]
2. HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation.
Monsef N; Soller M; Panagopoulos I; Abrahamsson PA
BMC Cancer; 2010 Jul; 10():385. PubMed ID: 20663134
[TBL] [Abstract][Full Text] [Related]
3. Low-affinity nerve growth factor receptors (p75LNGFR) in human prostate tissue: stromal localisation.
Paul A; Habib F
Urol Res; 1998; 26(2):111-6. PubMed ID: 9631943
[TBL] [Abstract][Full Text] [Related]
4. NGF-beta, NE-cells and prostatic cancer cell lines. A study of neuroendocrine expression in the human prostatic cancer cell lines DU-145, PC-3, LNCaP, and TSU-pr1 following stimulation of the nerve growth factor-beta.
Angelsen A; Sandvik AK; Syversen U; Stridsberg M; Waldum HL
Scand J Urol Nephrol; 1998 Feb; 32(1):7-13. PubMed ID: 9561567
[TBL] [Abstract][Full Text] [Related]
5. Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma.
Graham CW; Lynch JH; Djakiew D
J Urol; 1992 May; 147(5):1444-7. PubMed ID: 1373782
[TBL] [Abstract][Full Text] [Related]
6. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-MET/HGF receptor mRNA and protein in human non-malignant and malignant prostate tissues.
Tsuka H; Mori H; Li B; Kanamaru H; Matsukawa S; Okada K
Int J Oncol; 1998 Nov; 13(5):927-34. PubMed ID: 9772281
[TBL] [Abstract][Full Text] [Related]
8. Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma.
Arcuri F; Cintorino M; Florio P; Floccari F; Pergola L; Romagnoli R; Petraglia F; Tosi P; Teresa Del Vecchio M
Prostate; 2002 Aug; 52(3):167-72. PubMed ID: 12111693
[TBL] [Abstract][Full Text] [Related]
9. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
Monsef N; Soller M; Isaksson M; Abrahamsson PA; Panagopoulos I
Prostate; 2009 Jun; 69(9):909-16. PubMed ID: 19274762
[TBL] [Abstract][Full Text] [Related]
10. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate.
Djakiew D; Delsite R; Pflug B; Wrathall J; Lynch JH; Onoda M
Cancer Res; 1991 Jun; 51(12):3304-10. PubMed ID: 1710170
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines.
Pflug BR; Onoda M; Lynch JH; Djakiew D
Cancer Res; 1992 Oct; 52(19):5403-6. PubMed ID: 1382843
[TBL] [Abstract][Full Text] [Related]
12. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.
Pasquali D; Rossi V; Staibano S; De Rosa G; Chieffi P; Prezioso D; Mirone V; Mascolo M; Tramontano D; Bellastella A; Sinisi AA
Endocrinology; 2006 Sep; 147(9):4245-51. PubMed ID: 16763065
[TBL] [Abstract][Full Text] [Related]
13. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.
Monsef N; Helczynski L; Lundwall A; Påhlman S;
Prostate; 2007 Aug; 67(11):1219-29. PubMed ID: 17562539
[TBL] [Abstract][Full Text] [Related]
14. Expression of a Trk high affinity nerve growth factor receptor in the human prostate.
Pflug BR; Dionne C; Kaplan DR; Lynch J; Djakiew D
Endocrinology; 1995 Jan; 136(1):262-8. PubMed ID: 7828539
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue.
Hamdy FC; Autzen P; Robinson MC; Horne CH; Neal DE; Robson CN
Cancer Res; 1997 Oct; 57(19):4427-31. PubMed ID: 9331107
[TBL] [Abstract][Full Text] [Related]
17. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
18. Method for quantitation of low-abundance nerve growth factor mRNA expression in human nervous tissue using competitive reverse transcription polymerase chain reaction.
St Amand D; Pottage C; Henry P; Fahnestock M
DNA Cell Biol; 1996 May; 15(5):415-22. PubMed ID: 8924216
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor signaling following unilateral pelvic ganglionectomy in the rat ventral prostate is age dependent.
Podlasek CA; Ghosh R; Onur Cakir O; Bond C; McKenna KE; McVary KT
Asian J Androl; 2013 Nov; 15(6):764-9. PubMed ID: 23872662
[TBL] [Abstract][Full Text] [Related]
20. Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue.
Bründl J; Wallinger S; Breyer J; Weber F; Evert M; Georgopoulos NT; Rosenhammer B; Burger M; Otto W; Rubenwolf P
BMC Urol; 2018 Sep; 18(1):75. PubMed ID: 30176851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
